Tidalgo, Lilia .

HRN: 25-88-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2024
CEFUROXIME 1.5GM (VIAL)
09/18/2024
09/18/2024
IVT
1.5 Gm
On Cal Prior To OR
Elective Enucleation & Curettage
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: